-
Once-a-week injection shows promise as dual diabetes and weight loss treatment
Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly prescribed once-a-week injection... Read more -
New research reimagines primary care visits for people living with obesity
Navigating health care can be challenging under any circumstances, and systemic barriers can make the experience even more difficult for... Read more -
FDA clears OTC glucose monitoring system for weight management
The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose monitoring system for weight... Read more -
Fat-trapping microbeads provide drug-free weight loss in rats
Weight-loss interventions, including gastric bypass surgery and drugs that prevent dietary fat absorption, can be invasive or have negative side... Read more -
Imaging approach illuminates how weight loss drugs target the brain and pancreas
An international research team from Leibniz-FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging... Read more -
FDA approves Wegovy to treat serious liver disease
The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's popular weight-loss drug Wegovy to treat a serious form... Read more -
How cellular antennas regulate the development of precursor cells in fat tissue
Too much fat can be unhealthy: how fat cells, so-called adipocytes, develop, is crucial for the function of the fat... Read more -
A new understanding of amylin receptors could pave way for next generation of weight loss drugs
Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the... Read more -
GLP-1 drugs linked to reduced symptoms in chronic skin condition hidradenitis suppurativa
A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor agonists for hidradenitis suppurativa... Read more -
Fasting may affect metabolism and immune response differently in people with obesity
While fasting has become a popular trend, particularly for people who hope to lose weight, new UBC Okanagan research suggests... Read more -
Obese surgical patients can safely use GLP-1 therapy to reduce risk of complications, study concludes
Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of surgical... Read more -
Weight loss support before IVF could boost pregnancy chances—and reduce the need for treatment
Around 1 in 5 women of childbearing age are living with [obesity], defined by the World Health Organization as having... Read more -
Losing weight before IVF may increase chance of pregnancy
A systematic review and meta-analysis of randomized controlled trials (RCTs) assessed whether weight loss interventions before in vitro fertilization (IVF)... Read more -
Pharmacotherapy for the management of obesity—an updated guideline
Pharmacotherapy is an effective, evidence-based treatment for people living with obesity, as part of a long-term, individualized treatment plan. An... Read more -
Overlooked microproteins could treat obesity and metabolic disorders
The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide. This... Read more
